Global Vaccines: A Shot Of Growth For GSK And Pfizer?

Recent M&A activity in the vaccine industry has narrowed the pool of players. For companies that remain, the opportunity to reshape their positions in the global market comes with an even greater responsibility to contribute meaningfully to continued advances in global public health.

The modern era of preventative vaccines began over 200 years ago with Edward Jenner’s pioneering work on a vaccine to prevent smallpox. As science advanced, additional vaccines were developed to prevent a broad range of deadly or debilitating diseases, including cholera, rabies, tetanus, influenza, polio, and, in more recent years, meningitis, human papillomavirus, and rotavirus. This scientific work, coupled with progress in the delivery of vaccines to populations in need throughout the world, has resulted in millions of lives saved, virtually eliminating a number of diseases. Vaccines have been identified as one of the greatest public health achievements of all time.

In 2015, the global vaccine industry will have revenue of approximately $25 billion, most of which is attributable to a...

More from Deal-Making

More from In Vivo

Geopolitical Volatility Not Dimming A Healthy Mid-Term Outlook For Life Sciences Deals

 
• By 

New report by global law firm Taylor Wessing and Bayes Business School forecasts a steadily increasing volume of major life sciences M&A in the coming five years, but highlights concerns over cybersecurity and unrealistic valuations. Taylor Wessing partner Andrew Edge spoke to In Vivo.

Navigating the GLP-1 Opportunity In China: Strategic Imperatives For Western Pharma

 
• By 

The Chinese appetite for GLP-1s is noticeable. While the market opportunity for western pharma is huge, so are the strategic market access challenges, though not unsurmountable, L.E.K. Consulting told In Vivo.

Strategic Surprises: The Drugs That Rewrote The Forecasts

 

Many assets do not meet their pre-launch predictions, either exceeding or falling short of their forecast sales. In this article, In Vivo highlights several historic examples and the factors that influenced their unexpected performance.